Results 111 to 120 of about 61,036 (213)

Imipenem [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Detección fenotípica de metalobetalactamasas en aislados clínicos de Pseudomonas aeruginosa

Kasmera, 2012
: Pseudomonas aeruginosa is considered one of the most important hospital germs; its isolation is common in hospitalized patients. In addition, this microorganism has a marked multiresistance, which increases mortality.
Perozo-Mena Armindo José, Castellano-González Maribel Josefina, Ling-Toledo Eliana, Arraiz Nailet   +3 more
doaj  

Carbapenem-Hydrolyzing Metallo-ß-Lactamase from a Nosocomial Isolate of Pseudomonas aeruginosa in France

Emerging Infectious Diseases, 2000
Laurent Poirel, Louis Collet, P. Nordmann   +2 more
doaj   +1 more source

Hydrogen-Bonding Changes Cause Differences in Imipenem Breakdown Activity in OXA-48 Variants. [PDF]

J Chem Inf Model
Wang D, Mulholland AJ, Spencer J, van der Kamp MW.   +3 more
europepmc   +2 more sources

Antibiotic exposure and recovery of persister states influence virulence phenotypes in Pseudomonas aeruginosa. [PDF]

Arch Microbiol
da Cruz Nizer WS, Igídio CED, Ribeiro EM, Andrade ACO, de Oliveira SN, Teixeira MM, de Souza DDG, Fagundes CT.   +7 more
europepmc   +1 more source

Synergistic Effects of Amikacin With Imipenem and Ciprofloxacin Against Multidrug-Resistance Uropathogenic <i>Escherichia coli</i>. [PDF]

Can J Infect Dis Med Microbiol
Moharerpour SS, Ahmadi Parviji F, Javadi K, Halaji M.   +3 more
europepmc   +1 more source

<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]

JAC Antimicrob Resist
Yanagihara K, Tateda K, Doi Y, Takahashi S, Ohge H, Itahashi K, Okade H, Mikamo H.   +7 more
europepmc   +1 more source

Physiologically based pharmacokinetic modeling and dose adjustment of imipenem in pediatric patients with renal impairment. [PDF]

Front Cell Infect Microbiol
Feng C, Xiao P, Qu Y, Fan K, Wang Y, Zhang X, Wang X, Pan J, Deng Y, Yu Y.   +9 more
europepmc   +1 more source

Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024. [PDF]

Front Cell Infect Microbiol
Wise MG, Alekseeva I, Siddiqui F, Young K, Motyl MR, Sahm DF.   +5 more
europepmc   +1 more source

Development of a novel LC-MS/MS method for concurrent determination of imipenem, relebactam, and cilastatin in human serum, urine and peritoneal drainage fluid. [PDF]

BMC Chem
Yang X, Zhao C, Ding Y, Li Y, Zhao Y, Lin W, Li J, Wang D, Yue Z, Pei L, Jia M, Cao LL, Wang H.   +12 more
europepmc   +1 more source